Mark Iwicki
Vermögen: - $ am 31.05.2026
Vermögen: - $ am 31.05.2026
Herr Mark T. Iwicki ist Chairman bei Q32 Bio, Inc. und Chairman bei Akero Therapeutics, Inc. sowie unabhängiger Director bei Pulmatrix, Inc. und unabhängiger Non-Executive Director bei Merus NV, Chairman, President & Chief Executive Officer bei Kala Pharmaceuticals, Inc. und unabhängiger Director bei Aimmune Therapeutics, Inc. Er ist Mitglied des Board of Directors bei Pulmatrix, Inc, Merus NV, Nimbus Therapeutics LLC, Aimmune Therapeutics, Inc, Nimbus Apollo, Inc, Oxeia Biopharmaceuticals, Inc und Pulmatrix Operating Co, Inc. Herr Iwicki war zuvor als President, Chief Executive Officer & Director bei Civitas Therapeutics, Inc. tätig, als President, Chief Executive Officer & Director bei Blend Therapeutics, Inc. als President & Chief Executive Officer bei Sepracor Pharmaceuticals Inc, als Vice President bei Novartis Pharmaceuticals Corp, ein Vice President & Head-Cardiovascular Business Unit bei Novartis Pharmaceuticals UK Ltd. ein Principal bei Astra Merck, Inc. ein Principal bei Merck & Co. und ein President & Chief Executive Officer bei Sumitomo Dainippon Pharma Co., Ltd. Er war auch im Vorstand von TARIS BioMedical LLC und der Wellesley Youth Hockey Association. Er erhielt seinen Undergraduate-Abschluss von der Ball State University (Indiana) und einen MBA von der Loyola University Maryland, Inc.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
KALA BIO, INC. -.--% | 29.12.2025 | 0 ( -.--% ) | - $ | 31.05.2026 |
| 15.04.2026 | 0 ( -.--% ) | - $ | 31.05.2026 | |
-.--% | 12.06.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| THIRD HARMONIC BIO, INC. | Vorsitzender | 01.05.2020 |
| INHIBIKASE THERAPEUTICS, INC. | Vorstandsvorsitzender | 14.02.2025 |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Berater | - |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Vorsitzender | 22.12.2020 |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery research services | Direktor/Vorstandsmitglied | - |
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for respiratory infectious diseases | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| KALA BIO, INC. | Vorstandsvorsitzender | 11.02.2025 |
| MERUS N.V. | Vorsitzender | 01.07.2018 |
| AKERO THERAPEUTICS, INC. | Vorsitzender | 09.12.2025 |
| ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 26 |
|---|---|
Sumitomo Pharma Co., Ltd.
Sumitomo Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and other chemical products | Health Technology |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Pulmatrix Operating Co., Inc.
Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for respiratory infectious diseases | Health Technology |
TARIS BioMedical LLC
TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty pharmaceutical company which focuses on developing a pipeline of treatments for bladder diseases | Health Technology |
Kala Bio, Inc.
Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Operates as a clinical stage biotech company that develops molecule medicines for diseases like cancer, immune disorders and metabolic conditions | Health Technology |
Oxeia Biopharmaceuticals, Inc.
Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biotechnology company which develops therapeutics for mild traumatic brain injuries and neuro-metabolic dysfunctions | Health Technology |
Novartis Pharmaceuticals UK Ltd.
Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines and drugs | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Astra Merck, Inc.
Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Sells pharmaceuticals products | Health Technology |
Ball State University (Indiana)
Ball State University (Indiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola University Maryland, Inc.
Loyola University Maryland, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Merus NV
Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
Inhibikase Therapeutics, Inc.
Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Tarveda Therapeutics, Inc.
Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Health Technology |
Aimmune Therapeutics, Inc.
Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
Pulmatrix, Inc.
Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease | Health Technology |
Nimbus Apollo, Inc.
Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Provides drug discovery research services | Health Technology |
Wellesley Youth Hockey Association
Wellesley Youth Hockey Association Movies/EntertainmentConsumer Services Operates as an association for the improvement of hockey | Consumer Services |
Akero Therapeutics, Inc.
Akero Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for patients with metabolic diseases | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Develops immunomodulatory therapies with protein based molecules using a platform | Health Technology |
Aerovate Therapeutics, Inc.
Aerovate Therapeutics, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Third Harmonic Bio, Inc.
Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen